Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GOEV: mainly does just the base frame with off the shelf parts, so no clear moat from competitors except confirmation they nailed the price (which could be give-away) as they have no revenues.
MICS: short of the show premiere "Karaoke World Talent" in prime time
I foresee less demand impetus even with more visibility on store shelves.
Nile guy though may be dreaming to tame it to be a cult Meme stock? , but even if he blasts it to $20 can't see him selling the shares so fast to profit, must be another plan to entangle MISC in desperate handshake with some soundbite of their diversity plans to control some latest frenzy?
SMED had one of best value glances I notice now, a bit too late.
FRD: 41/2 years of the divy returned in one day now, but earlier 131/2 years on over 14% rise!
HOTH: .46:Not know if this data was not "tortured", as whole world awaits proper drug for this disease:
https://finance.yahoo.com/news/hoth-therapeutics-announces-ht-alz-142600477.html
MINM: new launch (today) in all top houses, do not know if it sells or smells?
https://www.amazon.com/Motorola-Reliable-Security-Parental-Controls/dp/B0B3NFFMX2/ref=sr_1_16?m=A1JCDPLP2335KA&marketplaceID=ATVPDKIKX0DER&qid=1657545845&s=merchant-items&sr=1-16
bbotcs: Lawn guy said he would do even a better job if ya give him the raise now.
AGRX .655 offering price buy.
DTIL 1.49 rebuy add.
AATC great back burner divy worker, but I need an official national traffic day
ceremony to drop everything buzzing around to be more attentive to it.
MKFG 1.85.......near year lows, Cathy Woods for a long time eager to wait this out. 3D had big collapse off old highs some eons ago after commanding astounding PE's., but faint breaths lately on wider applications? I do not own but
need to have a "feel" for this sector.
DTIL 1.59 small retake of my gem, want lower as coils better down under.
VHC need a big load to throw some pennies on this lotto like Blackrock:
https://newsfilter.io/a/da22e8669589238bd1458a7ab66eef4e
They do nothing except buy cushions for the chair during the big wait, and seem to have enough cash for research and snooping for eons.
OT: Don't fret, FRD div will pay for the lawn guy!
Curious if this helps, try this, if it works let me know:
https://www.biopharmcatalyst.com/sign-up?source=twitter_ad
FRD looks good long term, but I caution you to perhaps consider reinvesting the 2 cent quarterly dividend elsewhere to perhaps diversify.
MINM .33.top executive resigns (6:30 P.M.) not a minute to late as "she " might of monkeypoxed MINM, Salary will be saved ( reported no replacement)
to support incentivizing other top ex's if they are so inclined to go into the office.
DTIL 1.76 yoyo offerings on the big wait as recently 1.50's.
DTIL 1.76.
MICS 7.82 caught some splash and splatter from kiddie pool, so I can watch the kids play, but not enough to get my clothes wet.
DTIL sold 1/2 1.69 want lower but usually sorry as never catch the swings right before rocket.
New data followed by massive insider buying and elite Bio's offering attaching validating "help", usually sharpens the data veracity.
ELTK 3.83-I like too, but must consider:
https://www.prnewswire.com/il/news-releases/eltek-reports-that-it-has-resumed-making-deliveries-to-its-customers-301578872.html
During the big wait, one of the heros within our shareholders should attach some small id (WIFI) markers on their inventory so we can get the figures at same time head office does; this is also called "hands on shareholder protection security" in case newbies confused.........Ha, of course once cleared with legal pro bono staff.
JCTCF: 6.53.uhm ,having excess inventory bought cheaper may be extra scalp for this low low float Co. which has added employees at nice pace.?
Sale of their land mass could posit a nice PR clip, if they add they would knife their losing seed business in that parley and parlay...
DTIL 1.67 , been a few days since this level?
Ok moving toward same page....I do post my picks on that site to fend off obvious blunders I may make in addition to all the risky unknowns my investment style faces.
TMNA 1.15, praying for lower as did not have enough cash to buy more when .40.
Just to be clear , I like your approach, but just adding, that you can pose that question to me to the "higher" ups on that Bio board you linked , as some posters on that board worked with Nobel level research types, with chief moderator a self taught endpoint prodigy,
who could have earned millions if he was a shorting stock type.
You are correct, I do know a fellow who made good living advising these Co.'s how to promote and tweak offerings to keep payroll alive. ( he was on 9 boards).Dirty secret is that only 1% of drug trials are successful, but they offer great jump rope to capture speculative news flinches while ducking the dilutive offerings. And thank heaven's for such a process as it does philanthropic unintentional fostering of drug discover the Gov't will not enhance,
..after all, diseases can be decoded in time, it is just money and decades of snail pace advancement due to other priorities that keep this pace on low heat.
Your system is better than most as you seem to limit your risk tracking current book value and can scalp some giddy PR's not easily undersood for hours or days.
ISIG: 20 million win and stock up to 10.50 after 8.10 close before news..wonder if this under 2 million float stock which once soared to 35 has more upside?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169342589
ELEV; they have no revenue or reasonable prospects of earning a single penny before they burn more cash crushing their stand alone prospects in that category (continuous spending on committed focus to conclusion) ..Value may be a bet on a majority owner buying the shares and using the cash to rollup other Co's, or
they mastermind an ideal reverse merger with a better drug Co. with better prospects but short of cash.
ADVM: Google composite of their AI response to their min approach to these targets:
Adverum will no longer advance the gene therapy ADVM-022 in diabetic macular edema (DME) because of a dose-limiting toxicity, meaning the dose can not be escalated due to side effects. The biotech is forging ahead in wet age-related macular degeneration (wet AMD) but analysts have low expectations for the program.
Little mania dust spread for the hopefuls on dead crud.:
SIMPQ today $0.03 to 3.80 in just an hour
Show me one with no cash burn, as book value must be high to "contribute " the many millions to complete drug trial submissions.
Hey, I do not want to steal any dream worth much to the dreamer, as I also love the prospect of catching a lottery try..
Looked at TARA CABA and VINC,.same old story, each promising like 100's of others new avenues of promising patent protected strategies'. All good for science but not sure for shareholder ,as they need to plead their case to gullible philanthropic retail types ( like me) dreaming of discovering a new gem , starting with those stocks which have "open runways" (some cash) for another year. True no drug has ever been proven to fail ( no typo); so Co's can retro fit all studies with new trial change (uh, trial drug was not dosed enough, or at right time, or with wrong patient group, or with patients insufficiently given other drugs or conditions likely to make the primary drug work).
Got to remind myself to stay focused only on 3 conditions, massive insider buying , elite drug houses probing hard with shinny carrots, and platform scalable into billions focusing on unmet needs.
NEXI: I like DTIL better 1.53, both do allogeneic cell therapy,, both have some insider buying, but DTIL has revenue ,partners and cash to 2024 as just did the dilutive pipe sure shot dive.
I am no scientist so have to believe Novartis and Lilly picked over the important substance only computation rigor could discern.
7.81 8K share vol. snooze somebody gains?
SHIP .66 spun off some at 1 share USEA (3.18) for each 118 shares .figure SHIP shareholders lost another 25% or so waiting for this glory mastermind spin-off to lay out the shareholder's new value of both shares.?.
https://www.globenewswire.com/news-release/2022/07/06/2475105/0/en/Seanergy-Announces-Completion-of-United-Maritime-Corporation-Spin-Off.html
PLPL ditto >0012!